Innoviva (INVA) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -793.00 |
| Dec 31, 2025 | -1,659.00 |
| Sep 30, 2025 | -2,548.00 |
| Jun 30, 2025 | -2,283.00 |
| Mar 31, 2025 | -2,352.00 |
| Dec 31, 2024 | -2,796.00 |
| Sep 30, 2024 | -3,080.00 |
| Jun 30, 2024 | -3,038.00 |
| Mar 31, 2024 | -3,932.00 |
| Dec 31, 2023 | -5,354.00 |
| Sep 30, 2023 | -7,001.00 |
| Jun 30, 2023 | -7,260.00 |
| Mar 31, 2023 | -6,402.00 |
| Dec 31, 2022 | -5,578.00 |
| Sep 30, 2022 | -4,638.00 |
| Jun 30, 2022 | -3,316.00 |
| Mar 31, 2022 | -1,368.00 |
| Dec 31, 2021 | -1,079.00 |
| Sep 30, 2021 | -314.00 |
| Jun 30, 2021 | -65.00 |
| Mar 31, 2021 | 179.00 |
| Dec 31, 2020 | 1,637.00 |
| Sep 30, 2020 | 3,139.00 |
| Jun 30, 2020 | 3,533.00 |
| Mar 31, 2020 | 3,960.00 |
| Dec 31, 2019 | 4,192.00 |
| Sep 30, 2019 | 4,574.00 |
| Jun 30, 2019 | 4,768.00 |
| Mar 31, 2019 | 5,031.00 |
| Dec 31, 2018 | 6,791.00 |
| Sep 30, 2018 | 9,007.00 |
| Jun 30, 2018 | 9,059.00 |
| Mar 31, 2018 | 9,340.00 |
| Dec 31, 2017 | 6,057.00 |
| Sep 30, 2017 | 4,952.00 |
| Jun 30, 2017 | 4,534.00 |
| Mar 31, 2017 | 3,422.00 |
| Dec 31, 2016 | 7,938.00 |
| Sep 30, 2016 | 6,100.00 |